BioWorld

May 14, 2007

Biodel Makes Strong Debut On Nasdaq Following $75M IPO

Shares of Biodel Inc. shot up 19 percent on the first day of trading, as the company priced its initial public offering of 5 million shares at $15 apiece for gross proceeds of $75 million. (BioWorld Today) Read More

Pharmion Raises $120M Publicly To Fund Development Efforts

Cell Purification May Benefit Transplantation For Lupus

Senate Clears FDA Overhaul Bill, But House Moving More Slowly

Clinic Roundup

Appointments And Advancements

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 3, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 2, 2025.

AI-generated illustration of CAR T cells

Researchers arm CAR T cells to fight solid tumors

BioWorld

Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the...

Bioversys, Shionogi in CHF529M lung infection collaboration

BioWorld Science

Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on...

Medtronic receives CE mark for its Vitalflow ECMO system

BioWorld MedTech

Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...